RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
Biomarkers in Autosomal Dominant Cerebellar Ataxia
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Dalfampridine and Gait in Spinocerebellar Ataxias
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Trial in Adult Subjects With Spinocerebellar Ataxia
† Study has passed its completion date and status has not been verified in more than two years.